• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To register, simply click the Register button at the top right.

Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19

pattismith

pattismith

Senior Member
Messages
3,905
Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19 - ScienceDirect

https://doi.org/10.1016/j.clinph.2021.03.001

Highlights
Click to expand...
•
First study applying TMS in patients with fatigue and dysexecutive syndrome in the aftermath of COVID-19.
•
TMS studies revealed marked impairment of GABAergic intracortical inhibitory circuits within primary motor cortex.
•
TMS may serve as diagnostic tool in cognitive disturbances and fatigue in post-COVID-19 patients.
Click to expand...
 
You must log in or register to reply here.